Understanding heart disease in infants with genetic RAS mutations

This is a retrospective study — meaning researchers are looking back at medical records and genetic test results of patients who already have RASopathy-associated cardiomyopathy, a rare genetic condition that causes the heart muscle to thicken and can lead to heart failure, especially in infants. The study is gathering detailed information about how this disease develops and progresses over time. This information will help researchers design better clinical trials to test new treatments that target the underlying genetic cause of the disease.

Infants with this rare genetic heart condition face serious health risks, and doctors urgently need new treatment options. New medications being developed may help treat the root cause of the disease, but researchers first need to understand the natural history — how the disease unfolds — so they can properly test whether new treatments actually work. This study creates a carefully documented database that will serve as a reliable comparison group for future clinical trials.